Antimicrobial activity of ceftazidime-avibactam and comparators against levofloxacin-resistant Escherichia coli collected from four geographic regions, 2012–2018

por Stone, Gregory G., Hackel, Meredith A.
Publicado 2022

In Vitro Activity of Ceftibuten/VNRX-5236 against Urinary Tract Infection Isolates of Antimicrobial-Resistant Enterobacterales

por Karlowsky, James A., Hackel, Meredith A., Sahm, Daniel F.
Publicado 2022

In Vitro Activity of Ceftibuten-Avibactam against β-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program

por Karlowsky, James A., Hackel, Meredith A., Stone, Gregory G., Sahm, Daniel F.
Publicado 2023

In vitro activity of cefiderocol against MBL-producing Gram-negative bacteria collected in North America and Europe in five consecutive annual multinational SIDERO-WT surveillance...

por Takemura, Miki, Wise, Mark G, Hackel, Meredith A, Sahm, Daniel F, Yamano, Yoshinori
Publicado 2023

In Vitro Activity of Sulbactam-Durlobactam against Global Isolates of Acinetobacter baumannii-calcoaceticus Complex Collected from 2016 to 2021

por Karlowsky, James A., Hackel, Meredith A., McLeod, Sarah M., Miller, Alita A.
Publicado 2022

In Vitro Activity of Meropenem-Vaborbactam against Clinical Isolates of KPC-Positive Enterobacteriaceae

por Hackel, Meredith A., Lomovskaya, Olga, Dudley, Michael N., Karlowsky, James A., Sahm, Daniel F.
Publicado 2017

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including C...

por Hackel, Meredith A., Tsuji, Masakatsu, Yamano, Yoshinori, Echols, Roger, Karlowsky, James A., Sahm, Daniel F.
Publicado 2017

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in...

por Hackel, Meredith A., Tsuji, Masakatsu, Yamano, Yoshinori, Echols, Roger, Karlowsky, James A., Sahm, Daniel F.
Publicado 2018

In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019

por Karlowsky, James A., Hackel, Meredith A., Takemura, Miki, Yamano, Yoshinori, Echols, Roger, Sahm, Daniel F.
Publicado 2022

Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013–2015

por Karlowsky, James A., Hoban, Daryl J., Hackel, Meredith A., Lob, Sibylle H., Sahm, Daniel F.
Publicado 2017

In Vitro Activity of Gepotidacin against Gram-Negative and Gram-Positive Anaerobes

por Hackel, Meredith A., Karlowsky, James A., Canino, Michele A., Sahm, Daniel F., Scangarella-Oman, Nicole E.
Publicado 2022

Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-β-Lactamase-Positive Clinical Isolates of Enterobacterales from a 2018–2020 Global Surveillance...

por Karlowsky, James A., Wise, Mark G., Hackel, Meredith A., Pevear, Daniel C., Moeck, Greg, Sahm, Daniel F.
Publicado 2022

In Vitro Activity of Cefiderocol Against Meropenem-Nonsusceptible Gram-Negative Bacilli with Defined β-Lactamase Carriage: SIDERO-WT Surveillance Studies, 2014–2019

por Wise, Mark G., Karlowsky, James A., Hackel, Meredith A., Takemura, Miki, Yamano, Yoshinori, Echols, Roger, Sahm, Daniel F.
Publicado 2023

In Vitro Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobia...

por Karlowsky, James A., Hackel, Meredith A., Wise, Mark G., Six, David A., Uehara, Tsuyoshi, Daigle, Denis M., Cusick, Susan M., Pevear, Daniel C., Moeck, Greg, Sahm, Daniel F.
Publicado 2022